Kyotorphin
Kyotorphin is an endogenou neuroactive dipeptide with analgesic properties. Kyotorphin possesses anti-inflammatory and antimicrobial activity. Kyotorphin levels in cerebro-spinal fluid correlate negatively with the progression of neurodegeneration in Alzheimer's Disease patients[1].
Product Specifications
CAS Number
[70904-56-2]
UNSPSC
12352209
Hazard Statement
H315, H319
Target
Bacterial; Endogenous Metabolite
Type
Peptides
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/kyotorphin.html
Purity
99.79
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
N=C(N)NCCC[C@@H](C(O)=O)NC([C@H](CC1=CC=C(O)C=C1)N)=O
Molecular Formula
C15H23N5O4
Molecular Weight
337.37
Precautions
H315, H319
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
Human Endogenous Metabolite
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![JNK1 (MAPK8) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3B4H9]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
JNK1 (MAPK8) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3B4H9]
Lentiviral human AZU1 sgRNA gene knockout kit - Lentiviral human AZU1 sgRNA gene knockout kit (25)
ARHGAP28, ID (ARHGAP28, KIAA1314, Rho GTPase-activating protein 28, Rho-type GTPase-activating protein 28) (MaxLight 405)
ARHGAP28, ID (ARHGAP28, KIAA1314, Rho GTPase-activating protein 28, Rho-type GTPase-activating protein 28) (MaxLight 405)
